Cathie Wood’s ARK Invest sharply increased exposure to artificial intelligence and crypto-linked assets this week while reducing positions across software, biotech, and satellite communications.
The firm made its largest additions in CoreWeave (CRWV), Alphabet (GOOG), and Coinbase (COIN), while executing substantial cuts in Palantir (PLTR), GitLab (GTLB), and Exact Sciences (EXAS).
Major Weekly Buys
ARK Invest made its largest transaction of the week by acquiring 843,851 shares of CoreWeave, Inc., an AI-focused cloud infrastructure company operating within the Information Technology sector and IT Services industry. With a transaction value of $59.87 million, this move represents the strongest expression of ARK’s conviction in the AI compute supply chain.
ARK Invest added 174,293 shares of Alphabet (GOOG) for a total value of $56.3 million, signaling a strong vote of confidence in the company’s expanding AI capabilities. Alphabet is accelerating rollout of its Gemini model suite and integrating generative AI across Cloud, Search, and YouTube.
ARK acquired 33,837 shares of Meta Platforms (META) valued at $21.2 million. Meta continues aggressively scaling its AI infrastructure, including custom silicon, massive GPU clusters, and the Llama family of generative models.
Related to crypto, Ark Invest bought about $8.1 million of Circle (CRCL) and $2.04 million of Bullish (BLSH) stock in the last week, extending its crypto-equity buying even as both names traded lower.
Ark also purchased 77,363 shares of Coinbase’s (COIN) stock, worth roughly $20 million, averaging about $258 per share. Coinbase (COIN) has dropped roughly 21% over the past month, in line with the broader pullback across the crypto sector.
The Nov. 25 trades follow Ark’s larger Nov. 20 dip buy, when the firm accumulated hundreds of millions of dollars in crypto-related equities across its flagship ETFs as bitcoin crashed.
ARK continues to add shares of CRISPR Therapeutics (CRSP). The fund added 12,916 shares, totaling $6.23M exposure across funds. This further deepens investment in gene editing names ahead of expected data milestones in coming quarters.
ARK added 30,518 shares of Deere (DE) at a value of $14.67 million. This purchase strengthens ARK’s positioning in next-generation industrial automation beyond traditional tech.
Major Weekly Sells
ARK funds have been trimming positions in several of their top 10 holdings, specifically from Palantir and Advanced Micro Devices.
Cathie Wood’s ARK Invest executed a significant reduction in Palantir Technologies (PLTR), selling 354,955 shares for a total value of $57 million. Ark funds still hold shares worth market value of $503.8M.
ARK Invest made a dramatic reduction in GitLab Inc. (GTLB), dumping 1,272,824 shares totaling $52.57 million, making it one of ARK’s largest software exits this cycle. The fund has sold a total of $71.5M worth shares this November.
ARK Invest reduced its stake in Exact Sciences (EXAS), offloading 248,158 shares worth about $25.12 million. The selling follows news that the cancer diagnostics company will be acquired by Abbott Laboratories. Also , ~32K shares of Natera (NTRA), ~106K shares of Veracyte (VCYT), and ~58K shares of 10x Genomics (TXG) were reduced, reflecting a broad pullback in healthcare names.
ARK executed a sale of 106,651 shares of Advanced Micro Devices (AMD), totaling $21.4 million.
- Cathie Wood’s Ark Invest recap: pivots to AI drug discovery, gene editing stocks, reduces diagnostics and software exposure
- ARKQ: Betting On The Future At Triple-Digit P/Es Rarely Ends Well
- Perpetually grounded or ready to fly? The mystery of Tesla’s next-gen Roadster
- Correlation no more: Nasdaq’s comeback leaves bitcoin in the dust